[1]
“SGLT2 INHIBITORS BEYOND GLYCEMIC CONTROL: CARDIORENAL PROTECTION MECHANISMS IN TYPE 2 DIABETES MELLITUS ”, MPTTP, vol. 4, no. 9, pp. 62–64, Sep. 2026, Accessed: Oct. 07, 2026. [Online]. Available: https://universalpublishings.com/index.php/mpttp/article/view/20681